Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

NCT03042156 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03042156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03042156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
January 10, 2017
Completion date
April 30, 2025
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, immunotherapy, palliative, radiation therapy